| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |